Skip to content

Drug interactions

Dichlorphenamide + Insulin degludec / insulin aspart

Severity: Moderate

Dichlorphenamide and Insulin degludec / insulin aspart: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Insulin drives potassium into cells and can cause hypokalemia, while dichlorphenamide increases renal potassium loss. Together they can produce clinically significant hypokalemia, with a risk of weakness and arrhythmias.

What this interaction means in plain words

Dichlorphenamide and Insulin degludec / insulin aspart can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive hypokalemia from insulin-mediated cellular potassium uptake and carbonic anhydrase inhibitor-induced kaliuresis.

What to do

Monitor serum potassium regularly, particularly when starting or adjusting doses, and supplement potassium if low.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Insulin degludec / insulin aspart, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dichlorphenamide with Insulin degludec / insulin aspart?

MediHelp rates the interaction as moderate. Dichlorphenamide and Insulin degludec / insulin aspart can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Insulin drives potassium into cells and can cause hypokalemia, while dichlorphenamide increases renal potassium loss. Together they can produce clinically significant hypokalemia, with a risk of weakness and arrhythmias.

How serious is the interaction between Dichlorphenamide and Insulin degludec / insulin aspart?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium regularly, particularly when starting or adjusting doses, and supplement potassium if low.

What other medicines interact with Dichlorphenamide?

MediHelp also lists interactions of Dichlorphenamide with, for example, Acetazolamide, Acetylsalicylic acid, Ammonium chloride. The full list is on the Dichlorphenamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in